Skip to main content
TipRanks
Go Ultimate75% OFF

Wai Yuen Tong Medicine Holdings Limited (0897) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Wai Yuen Tong Medicine Holdings Limited has a market cap or net worth of HKD 406.75M. The enterprise value is HKD 560.58M.

Market Cap
HKD 406.75M
Enterprise Value
HKD 560.58M

Share Statistics

Wai Yuen Tong Medicine Holdings Limited has 1,114,382,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,114,382,900
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Wai Yuen Tong Medicine Holdings Limited’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is -1.16%.

Return on Equity (ROE)
0.00
Return on Assets (ROA)
0.00
Return on Invested Capital (ROIC)
-1.16%
Return on Capital Employed (ROCE)
-0.01
Revenue Per Employee
989.06K
Profits Per Employee
5,777.135
Employee Count
691
Asset Turnover
0.42
Inventory Turnover
1.42

Valuation Ratios

The current PE Ratio of Wai Yuen Tong Medicine Holdings Limited is 101.39. Wai Yuen Tong Medicine Holdings Limited’s PEG ratio is -0.19.

PE Ratio
101.39
PS Ratio
0.60
PB Ratio
0.34
Price to FCF
4.72
Price to Operating Cash Flow
4.06
PEG Ratio
-0.19

Income Statement

In the last 12 months, Wai Yuen Tong Medicine Holdings Limited had revenue of 683.44M and earned 3.99M in profits. Earnings per share was 0.00.

Revenue
683.44M
Gross Profit
361.93M
Operating Income
-17.10M
Pretax Income
3.63M
Net Income
3.99M
EBITDA
67.05M
Earnings Per Share (EPS)
0.00

Cash Flow

In the last 12 months, operating cash flow was 99.70M and capital expenditures -13.49M, giving a free cash flow of 86.21M billion.

Operating Cash Flow
99.70M
Free Cash Flow
86.21M
Free Cash Flow per Share
0.08

Dividends & Yields

Wai Yuen Tong Medicine Holdings Limited pays an annual dividend of HKD 0.03, resulting in a dividend yield of ―

Dividend Per Share
HKD 0.03
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
21.19%
Earnings Yield
0.99%

Stock Price Statistics

Beta
0.68
52-Week Price Change
-19.78%
50-Day Moving Average
0.36
200-Day Moving Average
0.33
Relative Strength Index (RSI)
49.95
Average Volume (3m)
667.09K

Important Dates

Wai Yuen Tong Medicine Holdings Limited upcoming earnings date is Dec 01, 2026, TBA (Not Confirmed).

Last Earnings Date
Jun 25, 2026
Next Earnings Date
Dec 01, 2026
Ex-Dividend Date
Aug 22, 2024

Financial Position

Wai Yuen Tong Medicine Holdings Limited as a current ratio of 1.40, with Debt / Equity ratio of 23.63%

Current Ratio
1.40
Quick Ratio
0.87
Debt to Market Cap
0.75
Net Debt to EBITDA
2.18
Interest Coverage Ratio
-0.97

Taxes

In the past 12 months, Wai Yuen Tong Medicine Holdings Limited has paid -445.00K in taxes.

Income Tax
-445.00K
Effective Tax Rate
-0.12

Enterprise Valuation

Wai Yuen Tong Medicine Holdings Limited EV to EBITDA ratio is 8.13, with an EV/FCF ratio of 6.41.

EV to Sales
0.81
EV to EBITDA
8.13
EV to Free Cash Flow
6.41
EV to Operating Cash Flow
5.54

Balance Sheet

Wai Yuen Tong Medicine Holdings Limited has HKD 147.44M in cash and marketable securities with HKD 279.29M in debt, giving a net cash position of -HKD 131.85M billion.

Cash & Marketable Securities
HKD 147.44M
Total Debt
HKD 279.29M
Net Cash
-HKD 131.85M
Net Cash Per Share
-HKD 0.12
Tangible Book Value Per Share
HKD 1.06

Margins

Gross margin is 52.96%, with operating margin of -2.36%, and net profit margin of 0.58%.

Gross Margin
52.96%
Operating Margin
-2.36%
Pretax Margin
0.53%
Net Profit Margin
0.58%
EBITDA Margin
9.95%
EBIT Margin
-2.36%

Analyst Forecast

The average price target for Wai Yuen Tong Medicine Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-8.30%
EPS Growth Forecast
-44.44%

Scores

Smart Score
7
AI Score
53